Its long-acting design extends receptor engagement compared to native amylin
Reviewing medical history and risks
proved to be one of the few trials that evaluated the therapeutic effects of colchicine by completing a single center, randomized, double-blind, placebo-controlled trial of 84 PD patients without calcified plaques (15)
Interestingly, one Smad7 antisense oligonucleotide, mongersen, was recently shown in a double-blind controlled trial to enhance the 15-day remission rate versus placebo in patients with Crohns disease (Monteleone 2015)
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for type 2 diabetes management
These data support an effect of IL-13 to decrease total and reduced GSH through high 15LO1, PEBP1, and GPX4 activity, which is partially compensated by (a) increased expression/activity of SLC7A11 to enhance new intracellular GSH production and (b) increased export of GSSG